How placenta protects babies from THC exposure

This groundbreaking research delves into how delta-9-tetrahydrocannabinol (THC) moves through the human placenta, with critical implications for understanding potential risks during pregnancy. Scientists discovered that specific protein transporters called ABC transporters play a crucial role in controlling how much THC can pass from a mother to her unborn child.

The study focused on P-glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP), two important transport proteins that act like biological gatekeepers in the placenta. By using a sophisticated cocktail of transport inhibitors, researchers found that these proteins significantly influence THC transfer, potentially reducing the amount of THC that reaches the developing fetus. This mechanism suggests a natural protective barrier that may limit direct exposure to the psychoactive compound.

These findings are particularly significant for pregnant individuals who use cannabis, highlighting the complex biological processes that can impact fetal development. While the research doesn't definitively conclude the full health implications, it provides important insights into how the human body might naturally regulate exposure to tetrahydrocannabinol during pregnancy.